Toll Free: 1-888-928-9744

Intra Ocular Lens (IOL) - Medical Devices Pipeline Assessment, 2015

Published: Dec 31, 2015 | Pages: 292 | Publisher: GlobalData | Industry: Medical Devices | Report Format: Electronic (PDF)

Intra Ocular Lens (IOL) - Medical Devices Pipeline Assessment, 2015

Summary

GlobalData's Medical Devices sector report, "Intra Ocular Lens (IOL) - Medical Devices Pipeline Assessment, 2015" provides an overview of Intra Ocular Lens (IOL) currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Intra Ocular Lens (IOL) pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Intra Ocular Lens (IOL) under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Intra Ocular Lens (IOL) and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to Buy

The report enables you to - 
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Intra Ocular Lens (IOL) under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product's current stage of development, territory and estimated launch date
 Table of Contents

1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 15

2 Introduction 16
2.1 Intra Ocular Lens (IOL) Overview 16

3 Products under Development 17
3.1 Intra Ocular Lens (IOL) - Pipeline Products by Stage of Development 17
3.2 Intra Ocular Lens (IOL) - Pipeline Products by Segment 18
3.3 Intra Ocular Lens (IOL) - Pipeline Products by Territory 19
3.4 Intra Ocular Lens (IOL) - Pipeline Products by Regulatory Path 20
3.5 Intra Ocular Lens (IOL) - Pipeline Products by Estimated Approval Date 21
3.6 Intra Ocular Lens (IOL) - Ongoing Clinical Trials 22

4 Intra Ocular Lens (IOL) - Pipeline Products under Development by Companies 23
4.1 Intra Ocular Lens (IOL) Companies - Pipeline Products by Stage of Development 23
4.2 Intra Ocular Lens (IOL) - Pipeline Products by Stage of Development 25

5 Intra Ocular Lens (IOL) Companies and Product Overview 31
5.1 Abbott Medical Optics, Inc. Company Overview 31
5.1.1 Abbott Medical Optics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 31
5.2 Adoptics AG Company Overview 37
5.2.1 Adoptics AG Pipeline Products & Ongoing Clinical Trials Overview 37
5.3 AkkoLens International BV Company Overview 38
5.3.1 AkkoLens International BV Pipeline Products & Ongoing Clinical Trials Overview 38
5.4 Alcon, Inc. Company Overview 39
5.4.1 Alcon, Inc. Pipeline Products & Ongoing Clinical Trials Overview 39
5.5 Anew Optics, Inc. Company Overview 54
5.5.1 Anew Optics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 54
5.6 Bausch & Lomb Incorporated Company Overview 55
5.6.1 Bausch & Lomb Incorporated Pipeline Products & Ongoing Clinical Trials Overview 55
5.7 Calhoun Vision, Inc. Company Overview 56
5.7.1 Calhoun Vision, Inc. Pipeline Products & Ongoing Clinical Trials Overview 56
5.8 Elenza, Inc. Company Overview 58
5.8.1 Elenza, Inc. Pipeline Products & Ongoing Clinical Trials Overview 58
5.9 Eye4Vision Ophthalmics International Company Overview 59
5.9.1 Eye4Vision Ophthalmics International Pipeline Products & Ongoing Clinical Trials Overview 59
5.10 EyeKon Medical, Inc. Company Overview 61
5.10.1 EyeKon Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 61
5.11 Hoya Surgical Optics, Inc. Company Overview 166
5.11.1 Hoya Surgical Optics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 166
5.12 HumanOptics AG Company Overview 167
5.12.1 HumanOptics AG Pipeline Products & Ongoing Clinical Trials Overview 167
5.13 Imperial Medical Technologies, Inc Company Overview 169
5.13.1 Imperial Medical Technologies, Inc Pipeline Products & Ongoing Clinical Trials Overview 169
5.14 InnFocus LLC Company Overview 174
5.14.1 InnFocus LLC Pipeline Products & Ongoing Clinical Trials Overview 174
5.15 Innovia LLC Company Overview 175
5.15.1 Innovia LLC Pipeline Products & Ongoing Clinical Trials Overview 175
5.16 LensGen, Inc. Company Overview 176
5.16.1 LensGen, Inc. Pipeline Products & Ongoing Clinical Trials Overview 176
5.17 Lenstec, Inc. Company Overview 177
5.17.1 Lenstec, Inc. Pipeline Products & Ongoing Clinical Trials Overview 177
5.18 London Eye Hospital Pharma Company Overview 178
5.18.1 London Eye Hospital Pharma Pipeline Products & Ongoing Clinical Trials Overview 178
5.19 Massachusetts Institute of Technology Company Overview 179
5.19.1 Massachusetts Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview 179
5.20 Meir Medical Center Company Overview 180
5.20.1 Meir Medical Center Pipeline Products & Ongoing Clinical Trials Overview 180
5.21 Morcher Gmbh Company Overview 181
5.21.1 Morcher Gmbh Pipeline Products & Ongoing Clinical Trials Overview 181
5.22 NuLens Ltd. Company Overview 216
5.22.1 NuLens Ltd. Pipeline Products & Ongoing Clinical Trials Overview 216
5.23 Oculentis GmbH Company Overview 218
5.23.1 Oculentis GmbH Pipeline Products & Ongoing Clinical Trials Overview 218
5.24 PowerVision, Inc. Company Overview 220
5.24.1 PowerVision, Inc. Pipeline Products & Ongoing Clinical Trials Overview 220
5.25 Presbeasy Company Overview 225
5.25.1 Presbeasy Pipeline Products & Ongoing Clinical Trials Overview 225
5.26 Rayner Intraocular Lenses Limited Company Overview 226
5.26.1 Rayner Intraocular Lenses Limited Pipeline Products & Ongoing Clinical Trials Overview 226
5.27 Sharklet Technologies, Inc. Company Overview 246
5.27.1 Sharklet Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 246
5.28 STAAR Surgical Company Company Overview 247
5.28.1 STAAR Surgical Company Pipeline Products & Ongoing Clinical Trials Overview 247
5.29 TEKIA, Inc. Company Overview 254
5.29.1 TEKIA, Inc. Pipeline Products & Ongoing Clinical Trials Overview 254
5.30 University of Rochester Company Overview 260
5.30.1 University of Rochester Pipeline Products & Ongoing Clinical Trials Overview 260
5.31 University of Tampere Company Overview 261
5.31.1 University of Tampere Pipeline Products & Ongoing Clinical Trials Overview 261
5.32 Visioneering Technologies, Inc. Company Overview 262
5.32.1 Visioneering Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 262
5.33 Washington University in St. Louis Company Overview 263
5.33.1 Washington University in St. Louis Pipeline Products & Ongoing Clinical Trials Overview 263
5.34 Xend Company Overview 264
5.34.1 Xend Pipeline Products & Ongoing Clinical Trials Overview 264
5.35 Z Lens LLC Company Overview 265
5.35.1 Z Lens LLC Pipeline Products & Ongoing Clinical Trials Overview 265

6 Intra Ocular Lens (IOL)- Recent Developments 266

7 Appendix 289
7.1 Methodology 289
7.2 About GlobalData 291
7.3 Contact Us 292
7.4 Disclaimer 292
List of Tables
Table 1: Intra Ocular Lens (IOL) - Pipeline Products by Stage of Development 17 Table 2: Intra Ocular Lens (IOL) - Pipeline Products by Segment 18 Table 3: Intra Ocular Lens (IOL) - Pipeline Products by Territory 19 Table 4: Intra Ocular Lens (IOL) - Pipeline Products by Regulatory Path 20 Table 5: Intra Ocular Lens (IOL) - Pipeline Products by Estimated Approval Date 21 Table 6: Intra Ocular Lens (IOL) - Ongoing Clinical Trials 22 Table 7: Intra Ocular Lens (IOL) Companies - Pipeline Products by Stage of Development 23 Table 8: Intra Ocular Lens (IOL) - Pipeline Products by Stage of Development 25 Table 9: Abbott Medical Optics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 31 Table 10: Intraocular Lens - Astigmatism - Product Status 32 Table 11: Intraocular Lens - Astigmatism - Product Description 32 Table 12: Intraocular Lens - Presbyopia - Product Status 33 Table 13: Intraocular Lens - Presbyopia - Product Description 33 Table 14: Modified Light Transmission IOL - Product Status 34 Table 15: Modified Light Transmission IOL - Product Description 34 Table 16: Synchrony Dual Optic Accommodating IOL - Enhanced Version - Product Status 35 Table 17: Synchrony Dual Optic Accommodating IOL - Enhanced Version - Product Description 35 Table 18: TECNIS-1 Monofocal IOL - Product Status 36 Table 19: TECNIS-1 Monofocal IOL - Product Description 36 Table 20: Adoptics AG Pipeline Products & Ongoing Clinical Trials Overview 37 Table 21: Shape-Changing Accommodating Intraocular Lens - Product Status 37 Table 22: Shape-Changing Accommodating Intraocular Lens - Product Description 37 Table 23: AkkoLens International BV Pipeline Products & Ongoing Clinical Trials Overview 38 Table 24: AkkoLens AIOL - Product Status 38 Table 25: AkkoLens AIOL - Product Description 38 Table 26: Alcon, Inc. Pipeline Products & Ongoing Clinical Trials Overview 39 Table 27: Accommodative Intraocular Lens - Product Status 40 Table 28: Accommodative Intraocular Lens - Product Description 40 Table 29: AcrySof Cachet Angle-Supported Phakic Lens - Product Status 41 Table 30: AcrySof Cachet Angle-Supported Phakic Lens - Product Description 41 Table 31: Acrysof IQ Restor +8 Multifocal Intraocular Lens - Product Status 42 Table 32: Acrysof IQ Restor +8 Multifocal Intraocular Lens - Product Description 42 Table 33: AcrySof IQ ReSTOR 3.0D Toric IOL - Product Status 43 Table 34: AcrySof IQ ReSTOR 3.0D Toric IOL - Product Description 43 Table 35: AcrySof IQ ReSTOR 3.0D Toric IOL Diopter Range Expansion - Product Status 44 Table 36: AcrySof IQ ReSTOR 3.0D Toric IOL Diopter Range Expansion - Product Description 44 Table 37: AcrySof IQ ReSTOR Distant Dominant 2.5D - Product Status 45 Table 38: AcrySof IQ ReSTOR Distant Dominant 2.5D - Product Description 45 Table 39: AcrySof IQ ReSTOR Multifocal Toric Lens - Product Status 46 Table 40: AcrySof IQ ReSTOR Multifocal Toric Lens - Product Description 46 Table 41: AcrySof IQ ReSTOR Toric IOL 2.5D - Product Status 47 Table 42: AcrySof IQ ReSTOR Toric IOL 2.5D - Product Description 47 Table 43: AcrySof IQ ReSTOR Toric IOL Diopter Range Expansion - Product Status 48 Table 44: AcrySof IQ ReSTOR Toric IOL Diopter Range Expansion - Product Description 48 Table 45: AcrySof IQ Toric Diopter Range Expansion - Product Status 49 Table 46: AcrySof IQ Toric Diopter Range Expansion - Product Description 49 Table 47: AcrySof IQ Toric IOL Low Diopter Range Expansion - Product Status 50 Table 48: AcrySof IQ Toric IOL Low Diopter Range Expansion - Product Description 50 Table 49: Intrepid IOL - Product Status 51 Table 50: Intrepid IOL - Product Description 51 Table 51: Alcon, Inc. - Ongoing Clinical Trials Overview 52 Table 52: AcrySof IQ ReSTOR Multifocal Toric Lens - Evaluation of the Visual Acuity After the Implantation of a ReSTOR +2.5 Diopters Intraocular Lens (ReSTOR SV25T0) in the Distance Dominant Eye, in Combination With a +3.0 Diopters ReSTOR Intraocular Lens (ReSTOR SN6AD1) in the Fellow Eye 53 Table 53: Anew Optics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 54 Table 54: Zephyr Lens - Product Status 54 Table 55: Zephyr Lens - Product Description 54 Table 56: Bausch & Lomb Incorporated Pipeline Products & Ongoing Clinical Trials Overview 55 Table 57: Sarfarazi Elliptical Accommodating IOL - Product Status 55 Table 58: Sarfarazi Elliptical Accommodating IOL - Product Description 55 Table 59: Calhoun Vision, Inc. Pipeline Products & Ongoing Clinical Trials Overview 56 Table 60: Light Adjustable Lens - Product Status 57 Table 61: Light Adjustable Lens - Product Description 57 Table 62: Elenza, Inc. Pipeline Products & Ongoing Clinical Trials Overview 58 Table 63: Sapphire Autofocal IOL - Product Status 58 Table 64: Sapphire Autofocal IOL - Product Description 58 Table 65: Eye4Vision Ophthalmics International Pipeline Products & Ongoing Clinical Trials Overview 59 Table 66: HYDROPHOBICx - Product Status 60 Table 67: HYDROPHOBICx - Product Description 60 Table 68: EyeKon Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 61 Table 69: ACUITY FA55A-4NY IOL - Product Status 64 Table 70: ACUITY FA55A-4NY IOL - Product Description 64 Table 71: Acuity FA55A-4UV IOL - Product Status 65 Table 72: Acuity FA55A-4UV IOL - Product Description 65 Table 73: Acuity FB25B - UV IOL - Product Status 66 Table 74: Acuity FB25B - UV IOL - Product Description 66 Table 75: Acuity FB25B-NY IOL - Product Status 67 Table 76: Acuity FB25B-NY IOL - Product Description 67 Table 77: Acuity FS25B-NY IOL - Product Status 68 Table 78: Acuity FS25B-NY IOL - Product Description 68 Table 79: Acuity FS25B-UV IOL - Product Status 69 Table 80: Acuity FS25B-UV IOL - Product Description 69 Table 81: Acuity FS60S - 4NY IOL - Product Status 70 Table 82: Acuity FS60S - 4NY IOL - Product Description 70 Table 83: Acuity FS60S - 4UV IOL - Product Status 71 Table 84: Acuity FS60S - 4UV IOL - Product Description 71 Table 85: Acuity SB25B IOL - Product Status 72 Table 86: Acuity SB25B IOL - Product Description 72 Table 87: Acuity SB25B-NY IOL - Product Status 73 Table 88: Acuity SB25B-NY IOL - Product Description 73 Table 89: Acuity TN60 - 2NY IOL - Product Status 74 Table 90: Acuity TN60 - 2NY IOL - Product Description 74 Table 91: Acuity TN60-OUV IOL - Product Status 75 Table 92: Acuity TN60-OUV IOL - Product Description 75 Table 93: Acuity UB60-0UV IOL - Product Status 76 Table 94: Acuity UB60-0UV IOL - Product Description 76 Table 95: Acuity UY60 - OUV IOL - Product Status 77 Table 96: Acuity UY60 - OUV IOL - Product Description 77 Table 97: Acurus AA55A-41 IOL - Product Status 78 Table 98: Acurus AA55A-41 IOL - Product Description 78 Table 99: Acurus AA55A-44 IOL - Product Status 79 Table 100: Acurus AA55A-44 IOL - Product Description 79 Table 101: Acurus AB25B IOL - Product Status 80 Table 102: Acurus AB25B IOL - Product Description 80 Table 103: Acurus AB25BNY IOL - Product Status 81 Table 104: Acurus AB25BNY IOL - Product Description 81 Table 105: Acurus AB60 - OUV IOL - Product Status 82 Table 106: Acurus AB60 - OUV IOL - Product Description 82 Table 107: ACURUS AR60S-4 IOL - Product Status 83 Table 108: ACURUS AR60S-4 IOL - Product Description 83 Table 109: Acurus AY60 - OUV IOL - Product Status 84 Table 110: Acurus AY60 - OUV IOL - Product Description 84 Table 111: Acurus SB25B - NY IOL - Product Status 85 Table 112: Acurus SB25B - NY IOL - Product Description 85 Table 113: Acurus SB25B IOL - Product Status 86 Table 114: Acurus SB25B IOL - Product Description 86 Table 115: ACURUS UN60-2NY IOL - Product Status 87 Table 116: ACURUS UN60-2NY IOL - Product Description 87 Table 117: ACURUS UN60-OUV IOL - Product Status 88 Table 118: ACURUS UN60-OUV IOL - Product Description 88


List of Figures
Figure 1: Intra Ocular Lens (IOL) - Pipeline Products by Stage of Development 17 Figure 2: Intra Ocular Lens (IOL) - Pipeline Products by Segment 18 Figure 3: Intra Ocular Lens (IOL) - Pipeline Products by Territory 19 Figure 4: Intra Ocular Lens (IOL) - Pipeline Products by Regulatory Path 20 Figure 5: Intra Ocular Lens (IOL) - Pipeline Products by Estimated Approval Date 21 Figure 6: Intra Ocular Lens (IOL) - Ongoing Clinical Trials 22

To request a free sample copy of this report, please complete the form below.

This website is secure and your personal details are safe. Privacy policy

Global Biocides market size is likely to be valued at USD 11.9 billion by 2022; as per a new research report by Radiant Insights, Inc. Growth in water treatment process units particularly in China, Japan and India is likely to drive demand. Increasin

Read More...

Global coated fabrics market size forecast is estimated at USD 22.57 billion by 2020; as per a new research report by Radiant Insights, Inc. Increasing production of seat covers & airbags for automobile applications is likely to favor market growth.

Read More...

Global CoQ10 market size was 687.2 tons in 2014 and is expected to reach 1,168 tons by 2020, growing at a CAGR of 9.2% from 2014 to 2020, according to a new study by Radiant Insights, Inc. Increasing scope in personal care applications is expected to

Read More...

Global electric water heaters market is expected to be valued at USD 29,322.4 million by 2022, as per a new research report by Radiant Insights, Inc. Escalating demand across extensive range of domestic applications is expected to drive demand. Evolv

Read More...

Global FPGA market is anticipated to be valued at USD 9,882.5 million by 2020, as per a new research report by Radiant Insights, Inc. Increasing demand for customized IC’s is expected to drive the demand. Customized IC’s helps manufacturers to mo

Read More...
Choose License Type
Single User - US $4000
Multi User - US $8000
Why Choose Us

24/5 Research support

Get your queries resolved from an industry expert. Request for a free product review before report purchase.

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Quality assurance

A testimonial for service excellence represented in the form of BBB "A" Accreditation.

Information security

Your personal and confidential information is safe and secure.

verify